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In 1959, William Russell and Rex
Burch published the seminal book, The
Principles of Humane Experimental Technique,
which emphasized reduction, refinement,
and replacement of animal use, principles
which have since been referred to as the
‘‘3 Rs’’. These principles encouraged
researchers to work to reduce the number
of animals used in experiments to the
minimum considered necessary, refine or
limit the pain and distress to which
animals are exposed, and replace the use
of animals with non-animal alternatives
when possible. Despite the attention
brought to this issue by Russell and Burch
and since, the number of animals used in
research and testing has continued to
increase, raising serious ethical and scien-
tific issues. Further, while the ‘‘3 Rs’’
capture crucially important concepts, they
do not adequately reflect the substantial
developments in our new knowledge about
the cognitive and emotional capabilities of
animals, the individual interests of ani-
mals, or an updated understanding of
potential harms associated with animal
research. This Overview provides a brief
summary of the ethical and scientific
considerations regarding the use of ani-
mals in research and testing, and accom-
panies a Collection entitled Animals, Re-
search, and Alternatives: Measuring Progress 50
Years Later, which aims to spur ethical and
scientific advancement.
Introduction
One of the most influential attempts to
examine and affect the use of animals in
research can be traced back to1959, with
the publication of The Principles of Humane
Experimental Technique [1]. William Russell
and Rex Burch published this seminal
book in response to marked growth in
medical and veterinary research and the
concomitant increase in the numbers of
animals used. Russell and Burch’s text
emphasized reduction, refinement, and
replacement of animal use, principles
which have since been referred to as the
‘‘3 Rs’’. These principles encouraged
researchers to work to reduce the number
of animals used in experiments to the
minimum considered necessary, refine or
limit the pain and distress to which
animals are exposed, and replace the use
of animals with non-animal alternatives
when possible.
Despite the attention brought to this
issue by Russell and Burch, the number of
animals used in research and testing has
continued to increase. Recent estimates
suggest that at least 100 million animals
are used each year worldwide [2]. How-
ever, this is likely an underestimate, and it
is impossible to accurately quantify the
number of animals used in or for exper-
imentation. Full reporting of all animal use
is not required or made public in most
countries. Nevertheless, based on available
information, it is clear that the number of
animals used in research has not signifi-
cantly declined over the past several
decades.
The ‘‘3 Rs’’ serve as the cornerstone for
current animal research guidelines, but
questions remain about the adequacy of
existing guidelines and whether research-
ers, review boards, and funders have fully
and adequately implemented the ‘‘3 Rs’’.
Further, while the ‘‘3 Rs’’ capture crucially
important concepts, they do not adequate-
ly reflect the substantial developments in
our new knowledge about the cognitive
and emotional capabilities of animals; an
updated understanding of the harms
inherent in animal research; and the
changing cultural perspectives about the
place of animals in society [3], [4]. In
addition, serious questions have been
raised about the effectiveness of animal
testing and research in predicting antici-
pated outcomes [5–13].
In August 2010, the Georgetown Uni-
versity Kennedy Institute of Ethics, the
Johns Hopkins University Center for Alter-
natives to Animal Testing, the Institute for
In Vitro Sciences, The George Washington
University, and the Physicians Committee
for Responsible Medicine jointly held a two
day multi-disciplinary, international confer-
ence in Washington, DC, to address the
scientific, legal, and political opportunities
and challenges to implementing alternatives
to animal research. This two-day sympo-
sium aimed to advance the study of the
ethical and scientific issues surrounding the
use of animals in testing and research, with
particular emphasis on the adequacy of
current protections and the promise and
challenges of developing alternatives to the
use of animals in basic research, pharma-
ceutical research and development, and
regulatory toxicology. Speakers who con-
tributed to the conference reviewed and
contributed new knowledge regarding the
cognitive and affective capabilities of ani-
mals, revealed through ethology, cognitive
psychology, neuroscience, and related dis-
ciplines. Speakers also explored the dimen-
sions of harm associated with animal
research, touching on the ethical implica-
tions regarding the use of animals in
research. Finally, several contributors pre-
sented the latest scientific advances in
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in pharmaceutical research and develop-
ment and regulatory toxicity testing.
This Collection combines some papers
that were written following this conference
with an aim to highlight relevant progress
and research. This Overview provides a
brief summary of the ethical and scientific
considerations regarding the use of ani-
mals in research and testing, some of
which are highlighted in the accompany-
ing Collection.
Analysis and Discussion
Ethical Considerations and Advances
in the Understanding of Animal
Cognition
Apprehension around burgeoning med-
ical research in the late 1800s and the first
half of the 20
th century sparked concerns
over the use of humans and animals in
research [14], [15]. Suspicions around the
use of humans were deepened with the
revelation of several exploitive research
projects, including a series of medical
experiments on large numbers of prisoners
by the Nazi German regime during World
War II and the Tuskegee syphilis study.
These abuses served as the impetus for the
establishment of the Nuremberg Code,
Declaration of Helsinki, and the National
Commission for the Protection of Human
Subjects of Biomedical and Behavioral
Research (1974) and the resulting Belmont
Report [16–18]. Today, these guidelines
provide a platform for the protection of
human research subjects, including the
principles of respect, beneficence, and
justice, as well as special protections for
vulnerable populations.
Laws to protect animals in research
have also been established. The British
Parliament passed the first set of protec-
tions for animals in 1876, with the Cruelty
to Animals Act [19]. Approximately ninety
years later, the U.S. adopted regulations
for animals used in research, with the
passage of the Laboratory Animal Welfare
Act of 1966 [20]. Subsequent national and
international laws and guidelines have
provided basic protections, but there are
some significant inconsistencies among
current regulations [21]. For example,
the U.S. Animal Welfare Act excludes
purpose-bred birds, rats, or mice, which
comprise more than 90% of animals used
in research [20]. In contrast, certain dogs
and cats have received special attention
and protections. Whereas the U.S. Animal
Welfare Act excludes birds, rats and mice,
the U.S. guidelines overseeing research
conducted with federal funding includes
protections for all vertebrates [22], [23].
The lack of consistency is further illustrat-
ed by the ‘‘U.S. Government Principles for
the Utilization and Care of Vertebrate
Animals Used in Testing, Research and
Training’’ which stress compliance with
the U.S. Animal Welfare Act and ‘‘other
applicable Federal laws, guidelines, and
policies’’ [24].
While strides have been made in the
protection of both human and animal
research subjects, the nature of these
protections is markedly different. Human
research protections emphasize specific
principles aimed at protecting the interests
of individuals and populations, sometimes
to the detriment of the scientific question.
This differs significantly from animal
research guidelines, where the importance
of the scientific question being researched
commonly takes precedence over the
interests of individual animals. Although
scientists and ethicists have published
numerous articles relevant to the ethics
of animal research, current animal re-
search guidelines do not articulate the
rationale for the central differences be-
tween human and animal research guide-
lines. Currently, the majority of guidelines
operate on the presumption that animal
research should proceed based on broad,
perceived benefits to humans. These
guidelines are generally permissive of
animal research independent of the costs
to the individual animal as long as benefits
seem achievable.
The concept of costs to individual
animals can be further examined through
the growing body of research on animal
emotion and cognition. Studies published
in the last few decades have dramatically
increased our understanding of animal
sentience, suggesting that animals’ poten-
tial for experiencing harm is greater than
has been appreciated and that current
protections need to be reconsidered. It is
now widely acknowledged by scientists
and ethicists that animals can experience
pain and distress [25–29]. Potential causes
of harm include invasive procedures,
disease, and deprivation of basic physio-
logical needs. Other sources of harm for
many animals include social deprivation
and loss of the ability to fulfill natural
behaviors, among other factors. Numerous
studies have demonstrated that, even in
response to gentle handling, animals can
show marked changes in physiological and
hormonal markers of stress [30].
Although pain and suffering are subjec-
tive experiences, studies from multiple
disciplines provide objective evidence of
animals’ abilities to experience pain.
Animals demonstrate coordinated re-
sponses to pain and many emotional states
that are similar to those exhibited by
humans [25], [26]. Animals share genetic,
neuroanatomical, and physiological simi-
larities with humans, and many animals
express pain in ways similar to humans.
Animals also share similarities with hu-
mans in genetic, developmental, and
environmental risk factors for psychopa-
thology [25], [26]. For example, fear
operates in a less organized subcortical
neural circuit than pain, and it has been
described in a wide variety of species [31].
More complex markers of psychological
distress have also been described in
animals. Varying forms of depression have
been repeatedly reported in animals,
including nonhuman primates, dogs, pigs,
cats, birds and rodents, among others [32–
34]. Anxiety disorders, such as post-
traumatic stress disorder, have been de-
scribed in animals including chimpanzees
and elephants [35], [36], [37].
In addition to the capacity to experience
physical and psychological pain or distress,
animals also display many language-like
abilities, complex problem-solving skills,
tool related cognition and pleasure-seek-
ing, with empathy and self-awareness also
suggested by some research. [38–44]. Play
behavior, an indicator of pleasure, is
widespread in mammals, and has also
been described in birds [45], [46]. Behav-
ior suggestive of play has been observed in
other taxa, including reptiles, fishes and
cephalopods [43]. Self-awareness, assessed
through mirror self-recognition, has been
reported for chimpanzees and other great
apes, magpies, and some cetaceans. More
recent studies have shown that crows are
capable of creating and using tools that
require access to episodic-like memory
formation and retrieval [47]. These find-
ings suggest that crows and related species
display evidence of causal reasoning,
flexible learning strategies, imagination
and prospection, similar to findings in
great apes. These findings also challenge
our assumptions about species similarities
and differences and their relevance in
solving ethical dilemmas regarding the use
of animals in research.
Predictive Value of Animal Data and
the Impact of Technical Innovations
on Animal Use
In the last decade, concerns have
mounted about how relevant animal
experiments are to human health out-
comes. Several papers have examined the
concordance between animal and human
data, demonstrating that findings in ani-
mals were not reliably replicated in human
clinical research [5–13]. Recent systematic
reviews of treatments for various clinical
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ies have been poorly predictive of human
outcomes in the fields of neurology and
vascular disease, among others [7], [48].
These reviews have raised questions about
whether human diseases inflicted upon
animals sufficiently mimic the disease
processes and treatment responses seen in
humans.
The value of animal use for predicting
human outcomes has also been questioned
in the regulatory toxicology field, which
relies on a codified set of highly standard-
ized animal experiments for assessing
various types of toxicity. Despite serious
shortcomings for many of these assays,
most of which are 50 to 60 years old, the
field has been slow to adopt newer
methods. The year 2007 marked a turning
point in the toxicology field, with publica-
tion of a landmark report by the U.S.
National Research Council (NRC), high-
lighting the need to embrace in vitro and
computational methods in order to obtain
data that more accurately predicts toxic
effects in humans. The report, ‘‘Toxicity
Testing in the 21
st Century: A Vision and
a Strategy,’’ was commissioned by the
U.S. Environmental Protection Agency,
partially due to the recognition of weak-
nesses in existing approaches to toxicity
testing [49]. The NRC vision calls for a
shift away from animal use in chemical
testing toward computational models and
high-throughput and high-content in vitro
methods. The report emphasized that
these methods can provide more predic-
tive data, more quickly and affordably
than traditional in vivo methods. Subse-
quently published articles address the
implementation of this vision for improv-
ing the current system of chemical testing
and assessment [50], [51].
While a sea change is underway in
regulatory toxicology, there has been
much less dialogue surrounding the re-
placement of animals in research, despite
the fact that far more animals are used in
basic and applied research than in regu-
latory toxicology. The use of animals in
research is inherently more difficult to
approach systematically because research
questions are much more diverse and less
proscribed than in regulatory toxicology
[52]. Because researchers often use very
specialized assays and systems to address
their hypotheses, replacement of animals
in this area is a more individualized
endeavour. Researchers and oversight
boards have to evaluate the relevance of
the research question and whether the
tools of modern molecular and cell
biology, genetics, biochemistry, and com-
putational biology can be used in lieu of
animals. While none of these tools on their
own are capable of replicating a whole
organism, they do provide a mechanistic
understanding of molecular events. It is
important for researchers and reviewers to
assess differences in the clinical presenta-
tion and manifestation of diseases among
species, as well as anatomical, physiolog-
ical, and genetic differences that could
impact the transferability of findings.
Another relevant consideration is how
well animal data can mirror relevant
epigenetic effects and human genetic
variability.
Examples of existing and promising
non-animal methods have been reviewed
recently by Langley and colleagues, who
highlighted advances in fields including
orthodontics, neurology, immunology, in-
fectious diseases, pulmonology, endocrine
and metabolism, cardiology, and obstetrics
[52].
Many researchers have also begun to
rely solely on human data and cell and
tissue assays to address large areas of
therapeutic research and development. In
the area of vaccine testing and develop-
ment, a surrogate in-vitro human immune
system has been developed to help predict
an individual’s immune response to a
particular drug or vaccine [53], [54]. This
system includes a blood-donor base of
hundreds of individuals from diverse
populations and offers many benefits,
including predictive high-throughput in
vitro immunology to assess novel drug
and vaccine candidates, measurement of
immune responses in diverse human
populations, faster cycle time for discov-
ery, better selection of drug candidates for
clinical evaluation, and reductions in the
time and costs to bring drugs and vaccines
to the market. In the case of vaccines, this
system can be used at every stage,
including in vitro disease models, antigen
selection and adjuvant effects, safety
testing, clinical trials, manufacturing, and
potency assays. When compared with data
from animal experiments, this system has
produced more accurate pre-clinical data.
The examples above illustrate how
innovative applications of technology can
generate data more meaningful to hu-
mans, and reduce or replace animal use,
but advances in medicine may also require
novel approaches to setting research
priorities. The Dr. Susan Love Research
Foundation, which focuses on eradicating
breast cancer, has challenged research
scientists to move from animal research
to breast cancer prevention research
involving women. If researchers could
better understand the factors that increase
the risk for breast cancer, as well as
methods for effective prevention, fewer
women would require treatment for breast
cancer. Whereas animal research is largely
investigator-initiated, this model tries to
address the questions that are central to
the care of women at risk for or affected by
breast cancer. This approach has facilitat-
ed the recruitment of women for studies
including a national project funded by the
National Institutes of Health and the
National Institute of Environmental
Health to examine how environment and
genes affect breast cancer risk. This study,
which began in 2002, could not have been
accomplished with animal research [55].
Similarly, any approach that emphasiz-
es evidence-based prevention would pro-
vide benefits to both animals and humans.
Resource limitations might require a
strategic approach that emphasizes diseas-
es with the greatest public health threats,
which increasingly fall within the scope of
preventable diseases.
Conclusion
It is clear that there have been many
scientific and ethical advances since the
first publication of Russell and Burch’s
book. However, some in the scientific
community are beginning to question
how well data from animals translates into
germane knowledge and treatment of
human conditions. Efforts to objectively
evaluate the value of animal research for
understanding and treating human disease
are particularly relevant in the modern
era, considering the availability of increas-
ingly sophisticated technologies to address
research questions [9]. Ethical objections
to the use of animals have been publically
voiced for more than a century, well
before there was a firm scientific under-
standing of animal emotion and cognition
[15]. Now, a better understanding of
animals’ capacity for pain and suffering
is prompting many to take a closer look at
the human use of animals [56].
Articles in the accompanying Collection
only briefly touch on the many scientific
and ethical issues surrounding the use of
animals in testing and research. While it is
important to acknowledge limitations to
non-animal methods remain, recent de-
velopments demonstrate that these limita-
tions should be viewed as rousing chal-
lenges rather than insurmountable
obstacles. Although discussion of these
issues can be difficult, progress is most
likely to occur through an ethically
consistent, evidence-based approach. This
collection aims to spur further steps
forward toward a more coherent ethical
framework for scientific advancement.
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